Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbogen vs Phenylephrine in Progressive Lacunar Infarction
NCT04839224Phase 3Terminated
- Sponsor
- Yonsei University
- Start
- Apr 2021
- Primary completion
- Oct 2022
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of carbogen in lacunar infarction (LACI), sponsored by Yonsei University. Started Apr 2021; status: terminated.
02
Drugs
carbogen
03
Conditions
lacunar infarction (LACI)
Beyond the preview
Go deeper on NCT04839224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839224.